文献速递肾小球疾病

凋亡细胞诱导的抗原特异性免疫调节治疗实验性抗MPO肾小球肾炎

Apoptotic Cell-Induced, Antigen-Specific Immunoregulation to Treat Experimental Antimyeloperoxidase GN.
PubMed 文献 · J Am Soc Nephrol · 2019-07-23

本研究在小鼠模型中,将免疫优势MPO肽段偶联至脾细胞并诱导凋亡,输注后观察对抗MPO肾小球肾炎的影响。结果显示MPO偶联凋亡脾细胞可诱导MPO特异性调节性T细胞,抑制自身免疫和肾炎,且该保护作用依赖于调节性T细胞。

要点

  • MPO偶联凋亡脾细胞诱导抗原特异性调节性T细胞,减轻抗MPO肾炎。
  • 保护作用依赖于调节性T细胞,去除后保护消失。
  • 过继转移CD4+T细胞可传递保护效应,证实抗原特异性免疫调节。

核心结论

  • 在小鼠模型中,给予偶联免疫优势MPO肽段的凋亡脾细胞可通过诱导抗原特异性耐受抑制抗MPO肾小球肾炎。

研究设计与样本

  • 小鼠模型:用ECDI将MPO409-428或对照OVA323-339肽偶联至脾细胞并诱导凋亡,比较MPO-Sp与OVA-Sp对anti-MPO GN的影响。
  • 通过MPO加佐剂免疫诱导自身免疫,低剂量抗GBM球蛋白触发肾炎。
  • 另比较从MPO-Sp或OVA-Sp处理小鼠转移CD4+T细胞至已建立anti-MPO自身免疫的受体小鼠的效果。

主要发现

  • MPO-Sp而非OVA-Sp增加MPO特异性外周来源CD4+Foxp3- 1型调节性T细胞,并减少抗MPO自身免疫和GN。
  • 去除调节性T细胞后,MPO-Sp不再保护抗MPO自身免疫或GN。
  • 接受MPO-Sp处理小鼠CD4+T细胞(而非OVA-Sp处理小鼠CD4+T细胞)的已建立自身免疫小鼠受到保护。

临床怎么用

  • 该策略为抗原特异性免疫调节治疗ANCA相关GN提供了临床前概念验证。

局限性

  • 研究仅在小鼠模型中进行,尚未在人体验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myeloperoxidase (MPO)-ANCA-associated GN is a significant cause of renal failure. Manipulating autoimmunity by inducing regulatory T cells is potentially a more specific and safer therapeutic option than conventional immunosuppression. METHODS: To generate MPO-specific regulatory T cells, we used a modified protein-conjugating compound, 1-ethyl-3-(3'dimethylaminopropyl)-carbodiimide (ECDI), to couple the immunodominant MPO peptide (MPO409-428) or a control ovalbumin peptide (OVA323-339) to splenocytes and induced apoptosis in the conjugated cells. We then administered MPO- and OVA-conjugated apoptotic splenocytes (MPO-Sps and OVA-Sps, respectively) to mice and compared their effects on development and severity of anti-MPO GN. We induced autoimmunity to MPO by immunizing mice with MPO in adjuvant; to trigger GN, we used low-dose antiglomerular basement membrane globulin, which transiently recruits neutrophils that deposit MPO in glomeruli. We also compared the effects of transferring CD4+ T cells from mice treated with MPO-Sp or OVA-Sp to recipient mice with established anti-MPO autoimmunity. RESULTS: MPO-Sp but not OVA-Sp administration increased MPO-specific, peripherally derived CD4+Foxp3- type 1 regulatory T cells and reduced anti-MPO autoimmunity and GN. However, in mice depleted of regulatory T cells, MPO-Sp administration did not protect from anti-MPO autoimmunity or GN. Mice with established anti-MPO autoimmunity that received CD4+ T cells transferred from mice treated with MPO-Sp (but not CD4+ T cells transferred from mice treated with OVA-Sp) were protected from anti-MPO autoimmunity and GN, confirming the induction of therapeutic antigen-specific regulatory T cells. CONCLUSIONS: These findings in a mouse model indicate that administering apoptotic splenocytes conjugated with the immunodominant MPO peptide suppresses anti-MPO GN by inducing antigen-specific tolerance.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Gan PY, Godfrey AS, Ooi JD, et al. Apoptotic Cell-Induced, Antigen-Specific Immunoregulation to Treat Experimental Antimyeloperoxidase GN. J Am Soc Nephrol. 2019. PMID: 31337690. doi:10.1681/ASN.2018090955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。